000 05689nam a22003855i 4500
001 76677
003 ES-MaUEC
005 20230207040234.0
007 cr nn 008mamaa
008 131014s2013 ii | s |||| 0|eng d
020 _a9788132211846
024 7 _a10.1007/978-81-322-1184-6
_2doi
050 4 _aRM301.3.G45
_bO45 2013 EB
082 0 4 _a610
245 0 0 _aOmics for personalized medicine
_cedited by Debmalya Barh, Dipali Dhawan, Nirmal Kumar Ganguly
260 _aNew Delhi
_bSpringer International Publishing
_c2013
300 _a1 recurso en línea (XVIII, 832 páginas)
_b103 ilustraciones, 68 ilustraciones en color
336 _aTexto (visual)
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
505 0 _aPharmaco-Geno-Proteo-Metabolomics and Personalized Medicine-An overview -- Personalized genome, current status and the future of harmacogenomic -- Next generation sequencing (NGS): a revolutionary technology in pharmacogenomics and personalized medicine -- Pharmaco-epigenomics -- Personalized nutrition and drug-nutrient interactions -- Designing and Implementing Pharmacogenomics Study -- Omics approaches and applications in Clinical Trials -- Ethical Considerations in Pharmacogenomics -- Computational Pharmacogenomics -- Pharmacogenomics in the era of personal genomics: a quick guide to online resources and tools -- Pharmacogenomics and Personalized Medicine for Cancer -- Pharmacogenomics in acute myeloid leukemia -- Pharmacogenomics of autoimmune diseases -- Pharmacogenomics and personalized medicine in Parkinsonism -- Pharmacogenomics and personalized medicine in Alzheimer{u2019}s disease -- Pharmacogenomics and Personalized Medicine in Mood Disorders -- Pharmacogenetics of opioid and alcohol addiction -- Neurogenetics and Nutrigenomics of Reward Deficiency Syndrome (RDS): Stratification of Addiction Risk and Mesolimbic Nutrigenomic Manipulation of Hypodopaminergic Function -- Pharmacogenomics of analgesics -- Cardiovascular Disease Pharmacogenomics -- Pharmacogenetics of Oral Anticoagulants -- Pharmacogenomics and personalized medicine of the antiplatelet drugs -- Pharmacogenomics of pulmonary and respiratory diseases -- Pharmacogenomics of Allergy and asthma -- Pharmacogenomics in Type 2 Diabetes mellitus and metabolic disorders -- Pharmacogenomics and Gut microbiota biomarkers in Obesity -- Pharmacogenomics and Personalized Medicine for Infectious Diseases -- Pharmacogenomics of Viral diseases -- Pharmacogenomics of osteoporosis-related bone fractures -- Pharmacogenomics of Gynaecological disorders -- Pharmacogenomics and Personalized medicine in Infertility -- Pharmacogenomics in Ophthalmology -- Personalized medicine in Cell Therapy and Transplantation -- Pharmacogenetics and pharmacogenomics of Chronic Kidney Disease comorbidities and Kidney transplantation
520 _ag2sOmics for Personalized Medicineg3s will give to its prospective readers the insight of both the current developments and the future potential of personalized medicine. The book brings into light how the pharmacogenomics and omics technologies are bringing a revolution in transforming the medicine and the health care sector for the better. Students of biomedical research and medicine along with medical professionals will benefit tremendously from the book by gaining from the diverse fields of knowledge of new age personalized medicine presented in the highly detailed chapters of the book. The book chapters are divided into two sections for convenient reading with the first section covering the general aspects of pharmaocogenomic technology that includes latest research and development in omics technologies. The first section also highlights the role of omics in modern clinical trials and even discusses the ethical consideration in pharmocogenomics. The second section is focusing on the development of personalized medicine in several areas of human health. The topics covered range from metabolic and neurological disorders to non-communicable as well as infectious diseases, and even explores the role of pharmacogenomics in cell therapy and transplantation technology. Thirty-four chapters of the book cover several aspects of pharmacogenomics and personalized medicine and have taken into consideration the varied interest of the readers from different fields of biomedical research and medicine. Advent of pharmacogenomics is the future of modern medicine, which has resulted from culmination of decades of research and now is showing the way forward. The book is an honest endeavour of researchers from all over the world to disseminate the latest knowledge and knowhow in personalized medicine to the community health researchers in particular and the educated public in general
942 _2lcc
_cLE
988 _aEBOOK, EBSPRINGERrevisando
650 7 _aFarmacogenómica
_9165192
_0comprobar BNE20051619502
_2embne
650 7 _aGenética humana
_0comprobar BNE19900986777
_2embne
_9140562
700 1 _aBarh, Debmalya
_eeditor literario
_985910
_0Local
700 1 _aDhawan, Dipali
_eeditor literario
_985911
_0Local
700 _aGanguly, Nirmal Kumar
_eeditor literario
_0Local
_985912
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-81-322-1184-6
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901 _ai9788132211846
907 _a.b12822954
_b07-11-17
_c01-10-14
998 _am
_a_alco
_a_vill
_b07-11-17
_cm
_dz
_eb
_feng
_gii
_h0
945 _aRM301.3 .G45 O45 2013 EB
_g1
_ieBOOK
_j0
_lmae
_o-
_pEUR0.00
_q-
_r-
_sb
_t15
_u0
_v0
_w0
_x0
_y.i11552165
_z06-04-17
999 _c76677
_d76677
_x1